Skip to menu Skip to content Skip to footer
Professor Haitham Tuffaha
Professor

Haitham Tuffaha

Email: 
Phone: 
+61 7 334 61156

Overview

Background

I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.

I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.

I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.

Availability

Professor Haitham Tuffaha is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, Griffith University

Research interests

  • Economic Evaluation of Healthcare Interventions

  • Health Technology Assessment

  • Value-Based Health Care

  • Cancer Economics

  • Medications use and safety

Research impacts

My research has significantly influenced health policy in Australia and internationally and was pivotal in the allocation of almost $1 billion in new drugs and medical technologies in Australia over the past ten years. My research program about evaluating new health technologies using Value of Information/implementation analyses led to a paradigm shift in the economic evaluation of new interventions and improved patient access to health innovations (e.g., genetic testing, targeted therapies). My research shifted the way clinical trials are prioritised and funded towards a value-based approach, which informed the development of the Australian Clinical Trials Alliance Research Prioritisation Framework.

I have published over 100 peer reviewed articles and technical reports for leading organisations, including 45 technical reports for the Australian Government on the economic evaluation of novel drugs, devices and services for a range of conditions including cancer, genetic testing, cardiovascular disease and liver disease.

Works

Search Professor Haitham Tuffaha’s works on UQ eSpace

163 works between 2005 and 2026

121 - 140 of 163 works

2018

Journal Article

Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers

Tuffaha, Haitham W., Mitchell, Andrew, Ward, Robyn L., Connelly, Luke, Butler, James R. G., Norris, Sarah and Scuffham, Paul A. (2018). Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 20 (9), 985-994. doi: 10.1038/gim.2017.231

Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers

2018

Conference Publication

Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia

Tuffaha, H. and Scuffham, P. (2018). Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.839

Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia

2018

Conference Publication

Can we prospectively assess the value for money of oncology clinical trials?

Tuffaha, Haitham, Chambers, Suzanne and Scuffham, Paul (2018). Can we prospectively assess the value for money of oncology clinical trials?. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, WA Australia, 13–15 November 2018. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.13089

Can we prospectively assess the value for money of oncology clinical trials?

2018

Conference Publication

Can technology improve medication adherence in older people with dementia?

El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Can technology improve medication adherence in older people with dementia?. 16th International Conference, ICOST 2018, Singapore, 10-12 July, 2018. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-94523-1_1

Can technology improve medication adherence in older people with dementia?

2018

Conference Publication

Value For Money, the Overlooked Aspect in Research Funding Decisions

Tuffaha, H., El-Saifi, N. and Scuffham, P. (2018). Value For Money, the Overlooked Aspect in Research Funding Decisions. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.413

Value For Money, the Overlooked Aspect in Research Funding Decisions

2017

Conference Publication

INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER

Maraiki, R., Bymes, J., Tuffaha, H. and Hider, M. (2017). INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER. NEW YORK: ELSEVIER SCIENCE INC.

INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER

2017

Journal Article

A program to increase research productivity among hospital pharmacists

Nazer, Lama H., Tuffaha, Haitham and Jaddoua, Saad (2017). A program to increase research productivity among hospital pharmacists. Journal of Pharmacy Practice, 30 (3), 336-341. doi: 10.1177/0897190016645432

A program to increase research productivity among hospital pharmacists

2017

Journal Article

Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia

Gordon, Louisa G., James, Robbie, Tuffaha, Haitham W., Lowe, Anthony and Yaxley, John (2017). Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. Journal of Magnetic Resonance Imaging, 45 (5), 1304-1315. doi: 10.1002/jmri.25504

Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia

2017

Journal Article

Health care and pharmacy practice in Jordan

Nazer, Lama H. and Tuffaha, Haitham (2017). Health care and pharmacy practice in Jordan. Canadian Journal of Hospital Pharmacy, 70 (2), 150-155. doi: 10.4212/cjhp.v70i2.1649

Health care and pharmacy practice in Jordan

2017

Journal Article

Setting medical research future fund priorities: assessing the value of research

Tuffaha, Haitham W., Andronis, Lazaros and Scuffham, Paul A. (2017). Setting medical research future fund priorities: assessing the value of research. Medical Journal of Australia, 206 (2), 64-65.e1. doi: 10.5694/mja16.00672

Setting medical research future fund priorities: assessing the value of research

2017

Conference Publication

International HTA experience with targeted therapy approvals For lung cancer

Maraiki, F., Byrnes, J., Tuffaha, H. and Hider, M. (2017). International HTA experience with targeted therapy approvals For lung cancer. ISPOR 20th Annual European Congress, Glasgow, United Kingdom, 4-8 November 2017. New York, NY USA: Elsevier. doi: 10.1016/j.jval.2017.08.335

International HTA experience with targeted therapy approvals For lung cancer

2017

Conference Publication

Improving patient access to novel cancer drugs in Australia: are we there yet?

Tuffaha, Haitham and Scuffham, Paul (2017). Improving patient access to novel cancer drugs in Australia: are we there yet?. COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Sydney, NSW Australia, 13-15 November 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Improving patient access to novel cancer drugs in Australia: are we there yet?

2016

Journal Article

How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia

Ball, Lauren, Lee, Patricia, Ambrosini, Gina L., Hamilton, Kyra and Tuffaha, Haitham (2016). How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia. Australian Journal of Primary Health, 22 (5), 383-387. doi: 10.1071/py16060

How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia

2016

Journal Article

Value of information analysis informing adoption and research decisions in a portfolio of health care interventions

Tuffaha, Haitham W., Gordon, Louisa G. and Scuffham, Paul A. (2016). Value of information analysis informing adoption and research decisions in a portfolio of health care interventions. MDM Policy & Practice, 1 (1), 238146831664223. doi: 10.1177/2381468316642238

Value of information analysis informing adoption and research decisions in a portfolio of health care interventions

2016

Journal Article

Cost-effectiveness analysis of nutritional support for the prevention of pressure ulcers in high-risk hospitalized patients

Tuffaha, Haitham W., Roberts, Shelley, Chaboyer, Wendy, Gordon, Louisa G. and Scuffham, Paul A. (2016). Cost-effectiveness analysis of nutritional support for the prevention of pressure ulcers in high-risk hospitalized patients. Advances in Skin and Wound Care, 29 (6), 261-267. doi: 10.1097/01.ASW.0000482992.87682.4c

Cost-effectiveness analysis of nutritional support for the prevention of pressure ulcers in high-risk hospitalized patients

2016

Journal Article

Efficient value of information calculation using a nonparametric regression approach: an applied perspective

Tuffaha, Haitham W., Strong, Mark, Gordon, Louisa G. and Scuffham, Paul A. (2016). Efficient value of information calculation using a nonparametric regression approach: an applied perspective. Value in Health, 19 (4), 505-509. doi: 10.1016/j.jval.2016.01.011

Efficient value of information calculation using a nonparametric regression approach: an applied perspective

2016

Other Outputs

Economic modelling of healthcare services for prostate cancer

Gordon, Louisa, Tuffaha, Haitham, James, Robbie and Scuffham, Paul (2016). Economic modelling of healthcare services for prostate cancer. Monographs in Prostate Cancer St Leonards, NSW, Australia: Prostate Cancer Foundation of Australia.

Economic modelling of healthcare services for prostate cancer

2016

Other Outputs

Value of Information Analysis Applications in Healthcare Interventions

Tuffaha, Haitham (2016). Value of Information Analysis Applications in Healthcare Interventions. PhD Thesis, School of Medicine , Griffith University. doi: 10.25904/1912/3508

Value of Information Analysis Applications in Healthcare Interventions

2016

Journal Article

Quetiapine safety in older adults: a systematic literature review

El-Saifi, N., Moyle, W., Jones, C. and Tuffaha, H. (2016). Quetiapine safety in older adults: a systematic literature review. Journal of Clinical Pharmacy and Therapeutics, 41 (1), 7-18. doi: 10.1111/jcpt.12357

Quetiapine safety in older adults: a systematic literature review

2015

Other Outputs

Transient elastography at 50Hz for the diagnosis of liver fibrosis in patients with hepatitis B or C: MSAC Assessment Report

Tuffaha, Haitham, Gordon, Louisa and Scuffham, Paul (2015). Transient elastography at 50Hz for the diagnosis of liver fibrosis in patients with hepatitis B or C: MSAC Assessment Report. Canberra, ACT Australia: Department of Health.

Transient elastography at 50Hz for the diagnosis of liver fibrosis in patients with hepatitis B or C: MSAC Assessment Report

Funding

Current funding

  • 2026 - 2030
    Buffered Solutions versus 0.9% Sodium Chloride for Intravenous Fluid Therapy to Improve Outcomes for Critically ill Children: The RESONANCE-PICU Multicentre, Binational Randomised Controlled Trial
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2026 - 2031
    IMPACT: Immunocellular Manufacturing Platform for Advanced Cell Therapies
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2026 - 2028
    Matching multidisciplinary management strategies to people with chronic musculoskeletal pain: the MATCH pilot and feasibility randomised clinical trial
    NHMRC MRFF Novel treatments and management strategies for chronic pain
    Open grant
  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2024 - 2028
    METASPATIAL Study: Metabolic Spatial Analysis of Lung Cancer Study
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2024 - 2029
    Paediatric Immune Cell Atlas for Immunotherapy Innovation (PICACHIU)
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2029
    BrainCAR19 Study- Treatment of relapsed Primary Brain Lymphoma with CD19 directed CAR-T cells
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant
  • 2024 - 2028
    Effectiveness of a Healthy Lifestyle and Resilience Program in New-Onset Rheumatoid Arthritis
    MRFF Clinician Researchers Applied Research in Health
    Open grant
  • 2024 - 2026
    BALANCE: Promoting wellBeing in AdoLescent and young Adult caNCEr survivors (NHMRC Partnership Grant led by Griffith Uni)
    Griffith University
    Open grant
  • 2023 - 2028
    ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
    ARC Industrial Transformation Research Hubs
    Open grant
  • 2023 - 2028
    Implementing integrated psychological and physical care for Australians after road traffic injury
    NHMRC MRFF Clinician Researchers: Nurses, Midwives and Allied Health Grant
    Open grant
  • 2023 - 2027
    Oral Health in Aged Care: Addressing Oral Health Inequity and Unmet Dental Care Needs of Vulnerable Population
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2027
    Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL)
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant

Past funding

  • 2025 - 2026
    Designing an Australian National Adaptive Platform Trial for Endometriosis
    MRFF Innovative Trials
    Open grant
  • 2024 - 2025
    Value-based assessment and cost-effectiveness analysis of two models of exercise oncology implementation
    Exercise and Sports Science Australia Ltd
    Open grant
  • 2023 - 2024
    Health economics analysis of animal plasma-derived antivenoms and antivenom distribution pathways for sub-Saharan Africa
    Global Snakebite Initiative USA Foundation
    Open grant
  • 2023
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study (RBWH Foundation Project Grant administered by Metro North Hospital)
    Metro North Hospital and Health Service
    Open grant
  • 2023 - 2025
    Research Alliance for Value-Based Care in Interventional Radiology
    Stryker Australia Pty Ltd
    Open grant
  • 2023
    Financial Efficiency Evaluation of PCFAs Prostate Cancer Specialist Nursing Program
    Prostate Cancer Foundation of Australia
    Open grant
  • 2022 - 2023
    Research Alliance for Value-Based Care in Interventional Radiology
    Stryker Australia Pty Ltd
    Open grant
  • 2022 - 2023
    The Value of Genetic Testing for Prostate Cancer
    Prostate Cancer Foundation of Australia
    Open grant
  • 2022 - 2023
    Efficacy and Effectiveness of Prophylactic fOam dressings in the prevention of saCral pressure injuries in at-risk hospitalised patients: The EEPOC Trial (NHMRC project grant administered by Griffith)
    Griffith University
    Open grant
  • 2022
    Cost-effectiveness analysis of lung cancer rehabilitation
    University of Melbourne
    Open grant
  • 2022
    Emerging and Adjunct treatments for PTSD and other mental health conditions affecting veterans: a rapid evidence assessment.
    Gallipoli Medical Research Foundation
    Open grant
  • 2021 - 2024
    BALANCE: Promoting wellBeing in AdoLescent and young Adult cancer survivors
    NHMRC Partnership Projects
    Open grant
  • 2021 - 2025
    Prostate Cancer Survivorship Essentials for Men with Prostate Cancer on Androgen Deprivation Therapy: Transforming Care to Improve Outcomes (NHMRC Partnership Projects administered by USQ)
    University of Southern Queensland
    Open grant
  • 2021 - 2022
    Spillover Effects of Military Service on Health and Wellbeing in Veteran Families
    Gallipoli Medical Research Foundation
    Open grant
  • 2021
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study
    Metro North Hospital and Health Service
    Open grant
  • 2020 - 2025
    EnhAnCing treatment oUtcoMes after gynaEcological caNcer (ACUMEN): Using exercise to promote health after cancer therapy
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2020
    Improving patient access to novel cancer drugs in Australia: striking the balance
    NHMRC Early Career Fellowships
    Open grant
  • 2017 - 2024
    ARC Training Centre for Innovation in Biomedical Imaging Technology
    ARC Industrial Transformation Training Centres
    Open grant

Supervision

Availability

Professor Haitham Tuffaha is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Evaluation of Indonesian Chronic Diseases Management Program: Patients participation, adherence to the treatment and cost-effectiveness of the program

    Principal Advisor

    Other advisors: Associate Professor Adam La Caze

Completed supervision

Media

Enquiries

Contact Professor Haitham Tuffaha directly for media enquiries about:

  • Cancer Economics
  • Health Economics
  • Health Services Research

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au